- Home
- MNKD vs DFIN Comparison
MNKD vs DFIN Comparison
Compare MNKD & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNKD | DFIN |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2004 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MNKD | DFIN |
|---|---|---|
| Price | $4.16 | $68.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $8.33 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.4M | 303.0K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.58 |
| Revenue | $348,966,000.00 | ★ $963,000,000.00 |
| Revenue This Year | $26.63 | $3.19 |
| Revenue Next Year | $14.81 | $4.12 |
| P/E Ratio | ★ N/A | $19.20 |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $2.23 | $36.11 |
| 52 Week High | $6.51 | $72.04 |
Technical Indicators
Market Signals| Indicator | MNKD | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 67.18 | 75.61 |
| Support Level | $3.77 | $45.59 |
| Resistance Level | $4.28 | $72.04 |
| Average True Range (ATR) | 0.19 | 2.82 |
| MACD | 0.09 | 0.46 |
| Stochastic Oscillator | 87.22 | 82.11 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance software solutions and related services provider. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. It operates in four reportable segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management (its key revenue-generating segment), Investment Companies - Software Solutions, and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States (USA), Europe, Asia, Canada, and Others, of which the USA accounts for the vast majority of its total revenue.